Heron Therapeutics | سود عملیاتی





سود عملیاتی تغییر دادن تاریخ
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
Amarin USD -1.7M 8.47M 2025-09
ANI Pharmaceuticals USD 22.83M 7.66M 2025-09
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
Insmed USD -261.35M 7.48M 2025-09
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Merck USD 6.24B 318M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 13.15M 2.92M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Surmodics USD -5.64M 276K 2024-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Veracyte USD 23.11M 8.8M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Heron Therapeutics سود عملیاتی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Feb 2026.